Clexio Biosciences is a CNS-first clinical-stage pharmaceutical company.

Our therapies are designed to address patients’ unmet needs through scientifically based integration of drugs with innovative technologies. 
 
Clexio’s growing pipeline is focused on the development of safe and effective treatments with rapid onset of action for a wide range of neurological and psychiatric conditions, including Major Depressive Disorder, Parkinson’s Disease, Pain and other conditions involving impairment of the neurological system.

Patients, and what they are living with, are at the center of everything we do.
Our passion is to find ways to help patients regain a sense of balance, health and a life worth living.

Clexio’s team is comprised of a multi-disciplinary team with vast experience in drug development. We see our team and our partners as the key ingredients to our success. 

Join our vision to make lives of millions of patients worth living again.



Neuroscience

Health & Wellness

Pharmaceutical

Life Sciences

Biotechnology

Clexio Biosciences

Elisabeth Kogan

Orly Eini

Lior Sahaf

Esther Hagai

The Leadership Team at Clexio Biosciences, comprising the Chief Medical Officer, CEO and Co-founder, and VP Business Development, spearheads the strategic direction and operational oversight of the company. This team's responsibilities include guiding clinical development, forging key partnerships, driving business growth, and ensuring that patient-centric goals remain at the forefront of the organization’s innovative drug development initiatives.

Leadership Team

Clinical and Medical Team

Leadership Team

About

Team members

Other teams at Clexio Biosciences

Clinical and Medical Team